SERVING CLIENTS NATIONWIDE

Roman J Sledziejowski Barred for Converting $4.8 Million in Fraudulent Scheme

FINRA barred TWS Financial, LLC President and Owner Roman Jerzy Sledziejowski for allegedly converting and/or misusing funds from multiple customers as part of a fraudulent scheme. The Authority additionally alleged that Sledziejowski attempted to conceal the misconduct by providing false account statements to some of these customers.

Disciplinary Proceeding #2012033559602

According to the findings, Sledziejowski perpetrated a fraudulent scheme in which $4.8 million was wired from customer bank and brokerage accounts to the Sledziejowski-owned Innovest Holdings LLC. Meanwhile, Sledziejowski allegedly attempted to conceal the wire transfers by providing two customers with fake account statements that falsely showed that funds and account balances in their TWS brokerage accounts were at appropriate and healthy levels.

FINRA found that Sledziejowski's fabricated numbers "differed significantly" from the customer's actual holdings in their TWS brokerage accounts.

The findings state that Sledziejowski wired funds from his customers' accounts to Innovest without their knowledge or consent.

Furthermore, Sledziejowski failed to cooperate with FINRA's investigation and in total, violated Section 10(b) of the Exchange Act and several FINRA and NASD Conduct Rules. Sledziejowski also previously worked at Salomon Smith Barney and was a Senior Vice President of Investments at Prudential Securities, Inc. and Wachovia Securities, LLC.

A native of Poland, Sledziejowski and firm TWS catered to Polish nationals, a group that comprised Sledziejowski's alleged fraud victims.

If you have invested with Roman Jerzy Sledziejowski or his firm TWS Financial, LLC, or with any other broker or firm you suspect has engaged in fraudulent or unethical conduct or has distributed false or misleading information, and such misconduct has proven harmful to your investments or interests, please call The Law Offices of Jonathan W. Evans & Associates at (800) 699-1881 for an investigation and consultation.

Categories